Palantir in the NHS: Why the Federated Data Platform Should Move Forward, Not Back

The conversation around the NHS Federated Data Platform has become distracted. This is not, at its core, a debate about Palantir. It is a test of whether the NHS is ready to operate as a modern, data-driven health system. Early evidence shows clear gains in productivity, improved patient flow, and faster clinical decision-making. The real risk is not the platform itself. It is the possibility that the NHS slows down or reverses progress at a moment when it can least afford to.

For decades, the NHS has operated within a fragmented digital environment. Data has sat in silos across trusts, departments, and legacy systems that rarely communicate with one another. Clinicians and operational teams have worked around these limitations with remarkable resilience, but the inefficiencies are well known: duplicated work, delayed decisions, and inconsistent patient experiences. The Federated Data Platform represents a deliberate shift away from that model, toward a system where information is connected, visible, and usable in real time.

What makes this shift meaningful is not the technology alone, but the operational outcomes it enables. When hospitals can see their waiting lists clearly, they can prioritise more effectively. When discharge data is aligned across teams, patients leave hospital sooner and beds become available for those who need them. When diagnostic pathways are tracked end to end, delays reduce and treatment begins earlier. These are not abstract improvements. They are measurable changes that directly affect patient care.

This is not a theoretical platform. It is already being applied across core operational and clinical domains.

Where the Federated Data Platform is Delivering Real Impact

Taken together, these capabilities are not incremental. They directly target the NHS’s biggest pressure points: waiting lists, workforce constraints, and patient flow. Even modest improvements across these areas compound quickly.

A 1–2% improvement in productivity across the NHS translates into roughly £150m to £300m or more in released capacity, before accounting for the wider gains from reduced length of stay, fewer missed appointments, and lower avoidable admissions. Reducing hospital stays by even a fraction of a day across thousands of patients frees up beds at scale. Improving attendance rates ensures clinical time is not wasted. Earlier intervention avoids more complex and expensive treatment later.

This is the real value of the Federated Data Platform. Not a single tool, but a coordinated system that improves outcomes while bending the cost curve in a service that urgently needs both.

It is important to understand what the platform is, and what it is not. It does not centralise ownership of data in the hands of a supplier. It does not remove control from individual trusts. Each organisation chooses whether to participate and operates within defined governance frameworks. Data remains under NHS control, used within strict rules and for defined purposes. The architecture is federated by design, allowing national coordination without compromising local accountability.

Governance is not a side issue, it is the foundation. For a platform of this scale to work, the rules around data use must be explicit and enforceable. Patient data must only ever be used for patient care and system improvement. Not for commercial exploitation. Not for any secondary use outside agreed boundaries. The NHS has both the leverage and the responsibility to ensure that this is the case through contract, oversight, and technical design.

The public debate has focused heavily on Palantir as a company. That is understandable, but it risks missing the point. The NHS does not need to decide whether it agrees with every aspect of a supplier’s wider activity. It needs to decide whether it is serious about building the infrastructure required to run a modern healthcare system. The question is not who provides the platform. It is whether the platform is delivering, and whether it is governed correctly.

If the NHS were to step away from the current approach, the consequences would be significant. Programmes already embedded across multiple trusts would need to be unwound. The process would likely take years. During that time, productivity gains would stall, and operational progress would reverse. At the same time, a new procurement would need to be run, costing millions and introducing further delay.

Alternative providers such as Oracle, Snowflake, Microsoft, and Amazon Web Services all bring strong capabilities. But they were not selected to deliver the full scope required. Each solves part of the problem. None, on its own, replaces an integrated operational platform at the scale the NHS requires.

Replacing one vendor with another does not solve fragmentation. It risks recreating it. The NHS has been here before, layering tools without achieving integration. The Federated Data Platform is an attempt to move beyond that cycle and create a coherent operational backbone.

There is also a strategic reality. The NHS is already behind where it should be on digital transformation. Other health systems are moving faster, investing in data infrastructure that improves both efficiency and outcomes. Falling further behind is not neutral. It directly affects patient care, access, and long-term sustainability.

At the centre of this effort are Ming Tang and Ayub Bhayat, whose work spans the Federated Data Platform, Single Patient Record, and NHS App, bringing these initiatives together into a single, system-wide programme focused on data-driven improvement and better patient outcomes. This is not a collection of isolated projects. It is a coordinated attempt to give the NHS a functioning data backbone. None of this means concerns should be ignored. Questions around ethics, governance, and trust are valid and necessary. The NHS must maintain the highest standards in how data is managed and protected. Public confidence depends on it. But the answer is to strengthen the framework, not abandon the progress. Contracts should be clear. Data usage should be tightly controlled. Oversight should be continuous. If there are gaps, they should be fixed. The NHS has the scale and leverage to set these conditions and enforce them.

Data is no longer a back-office function. It is central to how healthcare is delivered. From predicting deterioration to managing flow through hospitals, better data leads directly to better decisions. Without it, the system continues to operate below its potential. Patients are already ahead of this shift. They arrive informed, engaged, and expecting more responsive care. The NHS must meet that expectation with infrastructure that supports it.

The cost of stepping back now would not just be financial. It would be operational. Momentum would be lost. And in a system already under pressure, lost momentum is difficult to recover. The NHS cannot afford to move backwards. Not when the early results are clear. Not when the pressures are this high. And not when the tools to improve care are already in motion. The Federated Data Platform is not the end state. But it is a critical step. The priority now should be simple: build on what is working, tighten what needs control, and keep moving forward.